[go: up one dir, main page]

AU637861B2 - Improved system for the transdermal application of pharmacologically active compounds at controlled ph - Google Patents

Improved system for the transdermal application of pharmacologically active compounds at controlled ph

Info

Publication number
AU637861B2
AU637861B2 AU68757/91A AU6875791A AU637861B2 AU 637861 B2 AU637861 B2 AU 637861B2 AU 68757/91 A AU68757/91 A AU 68757/91A AU 6875791 A AU6875791 A AU 6875791A AU 637861 B2 AU637861 B2 AU 637861B2
Authority
AU
Australia
Prior art keywords
active compounds
pharmacologically active
controlled
transdermal application
improved system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU68757/91A
Other versions
AU6875791A (en
Inventor
Arun Rajaram Gupte
Uwe Rohr
Bernd Zierenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU6875791A publication Critical patent/AU6875791A/en
Application granted granted Critical
Publication of AU637861B2 publication Critical patent/AU637861B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention concerns the improved transdermal application of pharmacologically active compounds.
AU68757/91A 1989-12-01 1990-11-29 Improved system for the transdermal application of pharmacologically active compounds at controlled ph Expired AU637861B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3939703 1989-12-01
DE3939703A DE3939703C2 (en) 1989-12-01 1989-12-01 Improved transdermal application of pharmacologically active compounds

Publications (2)

Publication Number Publication Date
AU6875791A AU6875791A (en) 1991-06-26
AU637861B2 true AU637861B2 (en) 1993-06-10

Family

ID=6394557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68757/91A Expired AU637861B2 (en) 1989-12-01 1990-11-29 Improved system for the transdermal application of pharmacologically active compounds at controlled ph

Country Status (20)

Country Link
EP (1) EP0456792B1 (en)
JP (1) JPH04506811A (en)
KR (1) KR0143549B1 (en)
AT (1) ATE185492T1 (en)
AU (1) AU637861B2 (en)
CA (1) CA2046337C (en)
DE (2) DE3939703C2 (en)
DK (1) DK0456792T3 (en)
ES (1) ES2139570T3 (en)
FI (1) FI107707B (en)
GR (1) GR3032175T3 (en)
HU (1) HU206993B (en)
IE (1) IE904322A1 (en)
IL (1) IL96506A (en)
NO (1) NO302156B1 (en)
NZ (1) NZ236280A (en)
PT (1) PT96045B (en)
RU (1) RU1834665C (en)
WO (1) WO1991007998A1 (en)
ZA (1) ZA909624B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
JP3526887B2 (en) * 1993-04-23 2004-05-17 帝國製薬株式会社 Anti-inflammatory analgesic external patch
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
ES2251623T3 (en) 2001-12-21 2006-05-01 Coloplast A/S WOUND CARE DEVICE.
KR20190092313A (en) * 2018-01-30 2019-08-07 닛토덴코 가부시키가이샤 Transdermal absorption preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3912089A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag Multilayer plaster
AU4745390A (en) * 1988-12-01 1990-06-26 Schering Corporation Compositions for transdermal delivery of estradiol

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4830856A (en) * 1987-01-27 1989-05-16 Peppers James M Chelation product
DE3843557A1 (en) * 1988-12-23 1990-06-28 Beiersdorf Ag Transdermal therapeutic system for administering clenbuterol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3912089A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag Multilayer plaster
AU4745390A (en) * 1988-12-01 1990-06-26 Schering Corporation Compositions for transdermal delivery of estradiol

Also Published As

Publication number Publication date
DE3939703A1 (en) 1991-06-06
ES2139570T3 (en) 2000-02-16
FI107707B (en) 2001-09-28
RU1834665C (en) 1993-08-15
NO302156B1 (en) 1998-02-02
KR0143549B1 (en) 1998-07-01
CA2046337C (en) 2004-05-25
NO912985D0 (en) 1991-07-31
EP0456792B1 (en) 1999-10-13
HU206993B (en) 1993-03-01
IL96506A0 (en) 1991-08-16
NZ236280A (en) 1994-06-27
DE3939703C2 (en) 1998-07-02
ZA909624B (en) 1992-08-26
WO1991007998A1 (en) 1991-06-13
CA2046337A1 (en) 1991-06-02
DE59010885D1 (en) 1999-11-18
IE904322A1 (en) 1991-06-05
PT96045B (en) 1998-01-30
HU912638D0 (en) 1992-01-28
NO912985L (en) 1991-07-31
FI913645A0 (en) 1991-07-31
HUT59615A (en) 1992-06-29
GR3032175T3 (en) 2000-04-27
EP0456792A1 (en) 1991-11-21
DK0456792T3 (en) 2000-04-03
ATE185492T1 (en) 1999-10-15
PT96045A (en) 1991-09-13
JPH04506811A (en) 1992-11-26
AU6875791A (en) 1991-06-26
KR920700704A (en) 1992-08-10
IL96506A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
UA34466C2 (en) Agent for non-systemic control of parasites
AU594805B2 (en) Means for the application of transdermally absorbable active susbstances
AU3153097A (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
AU6613896A (en) Chemical compounds
YU48666B (en) MOMETASON FUROAT MONOHYDRATE AND PROCEDURE FOR ITS PRODUCTION
AU4019289A (en) Hiv protease inhibitors useful for the treatment of aids
MX9605023A (en) Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances.
BG102474A (en) (-)-cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidine-1-yletoxi)phenyl)-5,6,7 ,8-tetrahydronaphthalen-2-ol-d-tartarate
EP0310072A3 (en) Non-peptidyl beta-succinamidoacyl aminodiols as anti-hypertensive agents
JO1704B1 (en) New active compounds
AU4515996A (en) Methods for increasing the bioavailability of biological active agents
EP0313847A3 (en) Non-peptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents
NZ308516A (en) Transdermal therapeutic system (tts) for administering testosterone
AU4856290A (en) Stabilizing system for solid dosage forms
AU637861B2 (en) Improved system for the transdermal application of pharmacologically active compounds at controlled ph
AU610473B2 (en) 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ZA968550B (en) Novel processes for the preparation of anti-malarial compounds.
AU3774097A (en) Intermediates for the preparation of 2-imidazoline-5-ones
DK0934342T3 (en) Composition containing chitosan
AU5174099A (en) Use of stable concentrated water-in-oil emulsions for controlled transcutaneous release of an active principle
MX9703752A (en) Process and intermediate compounds for the preparation of pesticidal fluorolefin compounds.
MX9606264A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-i-ole compounds as pharmacologically active substances.
AU620084C (en) HIV protease inhibitors useful for the treatment of aids